Utility of SPECT Functional Neuroimaging of Pain

Area of Science:

• Neuroscience
• Radiopharmacology

Background:

• Functional neuroimaging often requires patients to be within a scanner, limiting clinical applications.
• Most modalities capture neural activity only during scanning.
• This restricts functional neuroimaging in challenging clinical settings.

Purpose of the Study:

• To highlight the utility of Single Photon Emission Tomography (SPECT) with Technetium 99m-labeled Ethyl Cysteinate Dimer (ECD) for functional brain imaging.
• To demonstrate its capability for imaging brain activity outside of a scanner.
• To showcase its application in clinical pain research.

Main Methods:

• Utilizing Technetium 99m-labeled Ethyl Cysteinate Dimer (ECD) as a radiopharmaceutical for SPECT brain imaging.
• Leveraging ECD's pharmacodynamics: blood-brain barrier crossing, neuronal extraction proportional to perfusion, and slow brain clearance.
• Exploiting the "snapshot" property of ECD to image brain perfusion at a later time point post-injection.

Main Results:

• ECD allows functional brain imaging up to 1-2 hours after injection, independent of scanner presence.
• SPECT-ECD imaging successfully captured brain activity during severe pain (e.g., burn wound care).
• The technique demonstrated the ability to image brain activity modulation in response to analgesia, including virtual reality.

Conclusions:

• SPECT with ECD overcomes the limitations of traditional functional neuroimaging by enabling off-scanner brain activity assessment.
• This method is particularly advantageous for studying brain function in extreme clinical conditions and pain research.
• It provides a flexible tool for investigating brain perfusion and activation patterns in various pain states, from experimental to chronic.